Small-airway disease and its reversibility in human immunodeficiency virus-infected children on highly active antiretroviral therapy: A cross-sectional study in an African setting

非洲地区接受高效抗逆转录病毒疗法的人类免疫缺陷病毒感染儿童小气道疾病及其可逆性:一项横断面研究

阅读:1

Abstract

BACKGROUND: Lung function abnormalities may occur in children with human immunodeficiency virus (HIV) infection. Small-airway disease (SAD) precedes abnormalities in forced expiratory volume in 1 s (FEV (1)). OBJECTIVE: This study aims to assess the presence and reversibility of SAD in HIV-infected children using the Global Lung Function Initiative standards. METHODS: A cross-sectional study was conducted over 6 months at the Paediatric HIV Clinic of the University of Nigeria Teaching Hospital in Enugu, Southeast Nigeria. Eligible consenting children with HIV infection were recruited. Lung function was measured, and the reversibility of FEV(1) and forced vital capacity (FVC) was assessed at 12% while that of forced expiratory flow between 25% and 75% (FEF(25-75)) was assessed at 12%, 15%, and 20%. Predictors of abnormal Z-score values were determined by multivariate linear and logistic regressions. Statistically significant values were set at P < 0.05. RESULTS: The mean Z-score for FEV(1), FVC, and FEF(25-75) was - 2.19, -1.86, and - 1.60, respectively. Most patients (73%) had abnormal FEV(1), while 52% had abnormal FEF(25-75). Significant changes in FEV(1) (P = 0.001) and FEF(25-75) (P < 0.001) occurred after the bronchodilator response (BDR) test. Of the children whose FEV(1) showed positive BDR, 70.9% had low zFEV(1;) 50% had low zFEF(25-75), while all had low FEV(1.) Nutritional status (Z-score for body mass index) was significantly associated with low FEV(1.) CONCLUSIONS: Abnormal FEF(25-75) as a marker of SAD and FEV(1) with a positive BDR are common in HIV-infected children. These lung function abnormalities justify long-term follow-up for these patients.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。